| The economic value of personalized medicine tests: what we know and what we need to know KA Phillips, J Ann Sakowski, J Trosman, MP Douglas, SY Liang, ... Genetics in Medicine 16 (3), 251-257, 2014 | 146 | 2014 |
| Barriers to the use of personalized medicine in breast cancer CB Weldon, JR Trosman, WJ Gradishar, AB Benson III, JC Schink Journal of Oncology Practice 8 (4), e24-e31, 2012 | 89 | 2012 |
| Genomic sequencing: assessing the health care system, policy, and big-data implications KA Phillips, JR Trosman, RK Kelley, MJ Pletcher, MP Douglas, ... Health affairs 33 (7), 1246-1253, 2014 | 77 | 2014 |
| Telehealth in oncology during the COVID-19 outbreak: bringing the house call back virtually R Liu, T Sundaresan, ME Reed, JR Trosman, CB Weldon, T Kolevska JCO Oncology Practice 16 (6), 289-293, 2020 | 71 | 2020 |
| Health technology assessment and private payers' coverage of personalized medicine JR Trosman, SL Van Bebber, KA Phillips Journal of Oncology Practice 7 (3S), 18s-24s, 2011 | 71 | 2011 |
| Coverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assay JR Trosman, SL Van Bebber, KA Phillips Journal of Oncology Practice 6 (5), 238-242, 2010 | 66 | 2010 |
| Payer coverage policies for multigene tests KA Phillips, PA Deverka, JR Trosman, MP Douglas, JD Chambers, ... Nature biotechnology 35 (7), 614-617, 2017 | 55 | 2017 |
| Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: Results of a study from the Program in Prenatal and Pediatric Genomic … JR Trosman, CB Weldon, A Slavotinek, ME Norton, MP Douglas, ... Genetics in medicine 22 (2), 283-291, 2020 | 52 | 2020 |
| Payer coverage for hereditary cancer panels: barriers, opportunities, and implications for the precision medicine initiative JR Trosman, CB Weldon, MP Douglas, AW Kurian, RK Kelley, ... Journal of the National Comprehensive Cancer Network 15 (2), 219-228, 2017 | 50 | 2017 |
| Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in JR Trosman, CB Weldon, RK Kelley, KA Phillips Journal of the National Comprehensive Cancer Network 13 (3), 311-318, 2015 | 49 | 2015 |
| Telemedicine in oncology and reimbursement policy during COVID-19 and beyond SM Kircher, M Mulcahy, A Kalyan, CB Weldon, JR Trosman, AB Benson Journal of the National Comprehensive Cancer Network 19 (13), 11-17, 2020 | 38 | 2020 |
| Attitudes and perceptions of multidisciplinary cancer care clinicians toward telehealth and secure messages E Neeman, D Kumar, L Lyon, T Kolevska, M Reed, T Sundaresan, A Arora, ... JAMA network open 4 (11), e2133877-e2133877, 2021 | 36 | 2021 |
| Care for a patient with cancer as a project: Management of complex task interdependence in cancer care delivery JR Trosman, RC Carlos, MA Simon, DL Madden, WJ Gradishar, ... Journal of oncology practice 12 (11), 1101-1113, 2016 | 35 | 2016 |
| Private payer coverage policies for exome sequencing (ES) in pediatric patients: trends over time and analysis of evidence cited MP Douglas, SL Parker, JR Trosman, AM Slavotinek, KA Phillips Genetics in medicine 21 (1), 152-160, 2019 | 34 | 2019 |
| Availability and payer coverage of BRCA1/2 tests and gene panels E Clain, JR Trosman, MP Douglas, CB Weldon, KA Phillips Nature biotechnology 33 (9), 900-902, 2015 | 27 | 2015 |
| “What goes around comes around”: lessons learned from economic evaluations of personalized medicine applied to digital medicine KA Phillips, MP Douglas, JR Trosman, DA Marshall Value in health 20 (1), 47-53, 2017 | 24 | 2017 |
| Emergence of hybrid models of genetic testing beyond direct-to-consumer or traditional labs KA Phillips, JR Trosman, MP Douglas Jama 321 (24), 2403-2404, 2019 | 23 | 2019 |
| From the past to the present: insurer coverage frameworks for next-generation tumor sequencing JR Trosman, CB Weldon, WJ Gradishar, AB Benson III, M Cristofanilli, ... Value in Health 21 (9), 1062-1068, 2018 | 23 | 2018 |
| Payer decision making for next-generation sequencing–based genetic tests: insights from cell-free DNA prenatal screening AP Dervan, PA Deverka, JR Trosman, CB Weldon, MP Douglas, ... Genetics in Medicine 19 (5), 559-567, 2017 | 23 | 2017 |
| Decision making on medical innovations in a changing health care environment: Insights from accountable care organizations and payers on personalized medicine and other … JR Trosman, CB Weldon, MP Douglas, PA Deverka, JB Watkins, ... Value in Health 20 (1), 40-46, 2017 | 23 | 2017 |
